Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

UPDATED

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Tucson Arizona 85719

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

California

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Los Angeles California 90404

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

San Francisco California 94158

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms

UPDATED

San Francisco California 94158

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

San Luis Obispo California 93422

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

San Luis Obispo California 93401

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Santa Maria California 93454

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Santa Maria California 93454

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Santa Monica California 90404

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Stanford California 94305

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Colorado

UPDATED

Lakewood Colorado 80228

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Lakewood Colorado 80228

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Florida

SCRI Florida Cancer Specialists
West Palm Beach Florida

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

UPDATED

Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Orlando Florida 32804

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota Florida 34232

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarasota Florida 34239

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Georgia

Northside Hospital
Atlanta Georgia

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Memorial University Medical Center
Savannah Georgia 31404

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Illinois

University of Chicago
Chicago Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Northwestern University
Evanston Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Indiana

IU Melvine and Bren Cancer Center
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

St. Vincent Hospital
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

UPDATED

Lafayette Indiana 47905

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Louisiana

Women’s Cancer Center
Covington Louisiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Maryland

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Baltimore Maryland 21237

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Massachusetts

Lahey Clinic
Burlington Massachusetts

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston Massachusetts 02215

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Boston Massachusetts 02114

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

Michigan

UPDATED

Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UPDATED

Detroit Michigan 48202

Patients are needed to participate in a clinical research study of FANG Autologous Tumor Cell Immunotherapy and Placebo to evaluate Ovarian Cancer or Ovarian Neoplasms